Optimising pre-analytical performance of interferon-gamma release assays for TB exposure.

Documents similaires

• Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.
  par: Thomas Stig Hermansen, et autres
  Publié: (2014-01-01)
• The Role of Interferon-Gamma Release Assays in Diagnosis of Latent Tuberculosis Infection in Children
  par: Mateja Šegović, et autres
  Publié: (2023-01-01)
• Evaluation of Diagnostic Performance of Three Commercial Interferon-Gamma Release Assays for <i>Mycobacterium tuberculosis</i>
  par: Richard Kutame, et autres
  Publié: (2024-09-01)
• Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes
  par: S.J.W. Kang, et autres
  Publié: (2024-10-01)
• Application and Interpretation of an Interferon-Gamma Release Assay: Results of an Audit in a Canadian Centre
  par: Sopharat Vat, et autres
  Publié: (2012-01-01)